Holly Meany
Children's National Research Institute · National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Holly Meany as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:25 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07172958 · Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)Children's National Research Institute · recruiting · Rhabdomyosarcoma, Ewing Sarcoma, Neuroblastoma · principal investigator
- Ph1NCT01518413 · Dose Escalation Study of Sorafenib and Irinotecan Combination Therapy in Pediatric Patients With Solid TumorsHMeany · completed · Rhabdomyosarcoma and Other Soft Tissue Sarcomas, Ewing's Sarcoma Family of Tumors, Osteosarcoma · principal investigator
- Ph1NCT00303940 · Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid TumorsNational Institutes of Health Clinical Center (CC) · completed · Brain and Central Nervous System Tumors, Childhood Germ Cell Tumor, Kidney Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ewing sarcoma.